Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.

Share:
More In Business
eDRV Offers EV Charging Management Solution
EV charging solution eDRV recently announced it closed a seed funding round. Bhaskar Deol, co-founder and CEO of eDRV, joined Cheddar News to explain how his company helps to launch and manage charging networks.
Load More